From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.
about
Liposomal delivery systems for intestinal lymphatic drug transportA Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.Addition of 20-kDa PEG to Insulin Lispro Alters Absorption and Decreases Clearance in Animals.Understanding the functions and relationships of the glymphatic system and meningeal lymphatics.Optimizing the Bioavailability of Subcutaneously Administered Biotherapeutics Through Mechanochemical Drivers.Self-Assembled Lipid Nanoparticles for Oral Delivery of Heparin-Coated Iron Oxide Nanoparticles for Theranostic Purposes.Strengths, weaknesses, opportunities and challenges for long acting injectable therapies: Insights for applications in HIV therapy.The lymphatic vasculature: development and role in shaping immunity.Nanoparticles for oral delivery: Design, evaluation and state-of-the-art.Lipid-Drug Conjugate for Enhancing Drug Delivery.microRNAs in the Lymphatic Endothelium: Master Regulators of Lineage Plasticity and Inflammation.Intestinal lymphatic vasculature: structure, mechanisms and functions.Novel strategies for the treatment of acute pancreatitis based on the determinants of severity: Okuda State-of the-Art Lecture.Pharmacokinetic and Toxicodynamic Characterization of a Novel Doxorubicin Derivative.Systemic effects in naïve mice injected with immunomodulatory lectin ArtinM.Albumin/vaccine nanocomplexes that assemble in vivo for combination cancer immunotherapy.Rational design of Polymeric Hybrid Micelles to Overcome Lymphatic and Intracellular Delivery Barriers in Cancer Immunotherapy.In vivo studies investigating biodistribution of nanoparticle-encapsulated rhodamine B delivered via dissolving microneedles.Bioactive-Chylomicrons for Oral Lymphatic Targeting of Berberine Chloride: Novel Flow-Blockage Assay in Tissue-Based and Caco-2 Cell Line Models.Organ-specific lymphatic vasculature: From development to pathophysiology.Subcutaneous drug delivery: An evolving enterprise.The Glymphatic System in Central Nervous System Health and Disease: Past, Present, and Future.Turning the Old Adjuvant from Gel to Nanoparticles to Amplify CD8+ T Cell Responses.Glyceride-Mimetic Prodrugs Incorporating Self-Immolative Spacers Promote Lymphatic Transport, Avoid First-Pass Metabolism, and Enhance Oral Bioavailability.Targeting Suppressive Oligonucleotide to Lymph Nodes Inhibits Toll-like Receptor-9-Mediated Activation of Adaptive Immunity.Integration of nano drug-delivery system with cancer immunotherapy.Capturing "Extraordinary" Soft-Assembled Charge-Like Polypeptides as a Strategy for Nanocarrier Design.Folic acid on iron oxide nanoparticles: platform with high potential for simultaneous targeting, MRI detection and hyperthermia treatment of lymph node metastases of prostate cancer.Dissolving Microneedle Arrays for Transdermal Delivery of Amphiphilic Vaccines.The Aging of Iron Man.Development of a mouse model for the visual and quantitative assessment of lymphatic trafficking and function by in vivo imaging.Growth and Immune Evasion of Lymph Node Metastasis.Physiological Perspective on Therapies of Lymphatic Vessels.Leveraging Physiology for Precision Drug DeliveryIncreased Oral Bioavailability of Resveratrol by Its Encapsulation in Casein NanoparticlesLipophilic activated ester prodrug approach for drug delivery to the intestinal lymphatic system
P2860
Q28067324-1482037B-782A-49AD-9419-544FB6A54175Q37003034-8FD8D1E8-BB13-49C3-8286-7F651A8853F1Q37389682-F50CB8C1-1601-4EDF-8DAB-FB77E082AC45Q38634466-87E18F73-5939-46D7-964A-C6CF60D41C71Q38657864-ED913C23-6C1B-4DD8-8771-EA318DA8B44BQ38700746-99A4F1FE-29CC-4F24-9843-AD9BB1AFE5A3Q38750666-EA624FF6-30DC-41D4-BC2A-FEB29366A66CQ38810930-0077F6FA-3290-4997-8571-7A96981323D3Q38862706-F8C9A9F5-0ECE-4234-9858-D8C00B510783Q39083391-4D4D2F90-0A4F-4B76-83C5-CBDA9BB6023EQ39148619-CC6E8EA3-2405-4AC3-A45B-02B650E1F259Q39401415-D1270DEF-19D6-45BF-9333-631C3333A50CQ40293885-4B9AE6B7-52EA-402A-B0B1-C77514EEBBB8Q42366841-4508D462-AAF6-422F-82DA-732595F388D2Q46186994-1C382298-905D-4F91-BB99-B820BDF73AADQ46205951-07039C20-FBF9-4889-9EB7-786A64981B34Q47099068-604F49F8-60C9-45C8-80E0-AE72075F9AB7Q47111251-FF9D2780-1BF2-4BE7-8172-630F49917631Q47228382-44B0B90D-16AD-427A-B5AD-028CCA828F64Q47248578-FAF9ECCC-E156-4F71-BBD4-943636115EEEQ47737747-293DD599-BA77-470A-B021-9EBCDE9CE511Q47806849-56CE1F5C-53B5-4113-9EEE-073B2A653780Q48154385-0A23E664-26B0-4AC1-8173-917C30EE4116Q48287245-4DAFDF14-2FD3-413E-AEBF-6B52B76C4F9EQ48504870-D77A7D2A-DCE4-4973-98B4-DBA93B6DA82BQ48622958-85B01899-5CD9-4234-8B3A-FD55560EDC5BQ48684399-2CD947F3-0C69-4039-BAA1-E86833B6C5AAQ50073061-3EA6010C-02B6-434D-A191-D3FEDA875329Q50863077-A14D7497-90C8-484E-87A3-35F86F9C543CQ51758684-1DB730DF-7FEB-4A03-B2CD-28C0FAC37CECQ52590922-B436776C-348B-43FB-B81B-5E0D7062CE6AQ55364617-560D6A60-4657-4531-B8C2-557D41A4B50BQ55426074-C65A4FF1-A6FD-4C72-BB93-686B901DB5ADQ57428850-A746AA0C-2E24-4326-9232-EC65510924F4Q58723030-901AE236-0C59-41EF-B2AC-B3EE4E684413Q59126730-23395AE4-0BD6-4BC5-9950-00BB9A6B4844
P2860
From sewer to saviour - targeting the lymphatic system to promote drug exposure and activity.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
From sewer to saviour - target ...... te drug exposure and activity.
@en
type
label
From sewer to saviour - target ...... te drug exposure and activity.
@en
prefLabel
From sewer to saviour - target ...... te drug exposure and activity.
@en
P2093
P50
P356
P1476
From sewer to saviour - target ...... ote drug exposure and activity
@en
P2093
Christopher J H Porter
Lisa M Kaminskas
Natalie L Trevaskis
P2888
P304
P356
10.1038/NRD4608
P577
2015-10-16T00:00:00Z